Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Jin Yang Pharmaceutical Co stock price, quote, forecast and news

007370.KQ
KR7007370000

Price

5,360.00
Today +/-
-0.01
Today %
-0.37 %
P

Jin Yang Pharmaceutical Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Jin Yang Pharmaceutical Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Jin Yang Pharmaceutical Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Jin Yang Pharmaceutical Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Jin Yang Pharmaceutical Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Jin Yang Pharmaceutical Co Stock Price History

DateJin Yang Pharmaceutical Co Price
9/24/20245,360.00 undefined
9/23/20245,380.00 undefined
9/20/20245,440.00 undefined
9/19/20245,360.00 undefined
9/13/20245,340.00 undefined
9/12/20245,280.00 undefined
9/11/20245,160.00 undefined
9/10/20245,250.00 undefined
9/9/20245,220.00 undefined
9/6/20245,120.00 undefined
9/5/20245,240.00 undefined
9/4/20245,390.00 undefined
9/3/20245,580.00 undefined
9/2/20245,460.00 undefined
8/30/20245,710.00 undefined
8/29/20245,710.00 undefined
8/28/20245,930.00 undefined
8/27/20245,770.00 undefined

Jin Yang Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jin Yang Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jin Yang Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jin Yang Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jin Yang Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jin Yang Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jin Yang Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jin Yang Pharmaceutical Co’s growth potential.

Jin Yang Pharmaceutical Co Revenue, EBIT and net profit per share

DateJin Yang Pharmaceutical Co RevenueJin Yang Pharmaceutical Co EBITJin Yang Pharmaceutical Co Net Income
202394.11 B undefined9.09 B undefined12.66 B undefined
202276.26 B undefined11.14 B undefined12.31 B undefined
202162.84 B undefined6.96 B undefined9.54 B undefined
202048.81 B undefined3.55 B undefined3.68 B undefined
201947.35 B undefined-216 M undefined1.65 B undefined
201846.86 B undefined1.47 B undefined933 M undefined
201743.45 B undefined-5.29 B undefined-5.77 B undefined
201636.13 B undefined-9.98 B undefined-9.1 B undefined
201540.15 B undefined-1.06 B undefined-1 B undefined
201445.24 B undefined6.12 B undefined4.01 B undefined
201340.24 B undefined4.88 B undefined4.19 B undefined
201237.15 B undefined4.01 B undefined2.53 B undefined
201136.26 B undefined368 M undefined1.06 B undefined
201040.86 B undefined3.35 B undefined3.49 B undefined
200950.39 B undefined8 B undefined6.54 B undefined
200842.26 B undefined3.63 B undefined1.12 B undefined
200733.06 B undefined-1.31 B undefined-242 M undefined
200634.06 B undefined2.93 B undefined1.64 B undefined
200531.95 B undefined6.18 B undefined3.72 B undefined
200430.28 B undefined6.97 B undefined4.72 B undefined

Jin Yang Pharmaceutical Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
9.711.8215.9120.2625.0328.6530.2831.9534.0633.0642.2650.3940.8636.2637.1540.2445.2440.1536.1343.4546.8647.3548.8162.8476.2694.11
-21.8134.5627.4123.4914.485.695.546.58-2.9427.8519.23-18.92-11.252.448.3212.43-11.25-10.0120.257.861.043.0828.7421.3623.40
51.9853.8361.8660.2862.9265.7566.5765.9366.2663.3666.0164.9559.4556.7758.9359.8261.9155.5947.8352.7055.0350.8252.3854.0859.8661.05
5.046.369.8412.2215.7518.8420.1621.0722.5720.9427.932.7324.2920.5921.8924.072822.3217.2822.925.7924.0625.5733.9845.6557.46
1.361.753.414.666.656.416.976.182.93-1.313.6383.350.374.014.886.12-1.06-9.98-5.291.47-0.223.556.9611.149.09
14.0414.7921.4123.0026.5722.3623.0219.338.60-3.958.5815.888.201.0110.7812.1413.54-2.65-27.62-12.183.13-0.467.2611.0814.609.65
0.341.082.523.454.574.644.723.721.64-0.241.126.543.491.062.534.194.01-1-9.1-5.770.931.653.689.5412.3112.66
-219.23133.3637.0132.491.441.68-21.10-56.05-114.80-564.05482.37-46.70-69.65138.8565.93-4.29-125.02806.27-36.61-116.1876.53123.25159.3729.062.85
--------------------------
--------------------------
6678810111012121111111111111111111111111111.4113.4412.48
--------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Jin Yang Pharmaceutical Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Jin Yang Pharmaceutical Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (B)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (B)EQUITY (B)LIABILITIES (B)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
2.530.691.82.54.463.984.2811.811.3610.667.6713.3413.3115.0119.3918.8711.126.510.961.692.775.465.3314.8710.498.6
8.649.1611.0111.3913.6716.7521.1421.119.5315.5317.1518.3720.4516.314.8318.0724.3623.4316.0112.6516.3713.5313.4916.6819.9221.76
0000.350.910.541.11.221.351.612.622.471.421.841.561.751.952.691.862.232.492.281.950.330.330.03
0.881.071.291.351.711.331.491.622.673.823.5644.384.454.724.185.475.596.916.837.256.77.879.0615.4217.35
0.030.030.040.010.050.040.020.160.030.210.540.040.030.040.021.142.12.660.458.040.960.120.070.060.160.29
12.0910.9514.1415.5920.8122.6428.0235.8934.9531.8331.5438.2239.5837.6540.5244.0244.9940.8826.1931.4329.8428.0828.714146.3348.03
1.241.344.114.268.1812.5412.5412.7713.2413.1424.7425.4919.6319.5819.319.2820.9935.2438.9129.1529.5228.5127.7639.3643.7944.14
1.112.181.732.1410.430.571.251.281.212.071.128.098.378.498.428.498.578.99.057.358.638.8915.8619.1420.21
574889168182176182391595662742960231267168149019520514100000300
0000.050.10.0400000.280.361.441.131.092.272.052.021.771.751.491.51.511.874.986.52
00000000000000000000000000
00000000000000000.1600.812.331.871.561.210.40.210.72
2.43.565.936.619.4613.1813.2914.4115.1215.0127.8227.9329.3929.3529.0430.1131.6946.0250.5942.4240.2240.239.3757.568.1271.88
14.4814.5120.0722.230.2735.8241.3150.350.0746.8459.3666.1568.986769.5674.1376.6886.976.7973.8570.0668.2868.0898.5114.44119.91
                                                   
2.22.53.23.23.2556666666666666666666.01
002.242.242.242.412.419.69.69.69.69.69.69.69.69.69.69.69.69.69.69.69.69.69.69.71
4.315.317.019.8214.3918.3922.123.0923.5222.0922.0727.4739.1738.6640.1642.7246.1743.933.8627.127.2927.9130.440.6351.8862.15
000000000000055-5-5-321-316-31624242424.0724.0724.07
002.92.92.92.92.92.92.92.911.8611.862.732.732.722.722.720002.213.23.3612.1415.7117.33
6.517.8115.3518.1622.7328.6932.4141.5942.0240.5949.5354.9357.55758.4961.0464.4959.1849.1542.3845.1246.7449.3868.3983.2295.23
0.20.180.320.460.80.780.610.810.7511.271.562.61.932.863.273.732.73.542.852.813.352.720.272.542.44
0.140.250.430.620.60.520.680.920.761.441.831.71.351.191.541.641.990002.712.723.142.882.823.62
0.160.691.341.321.711.512.22.071.52.12.23.793.483.043.115.174.015.225.74.665.284.754.9915.2215.4810.71
4.852.610.520.30.640.31.170.691.130.30.580.30.30.20023.311.792.740.38960.630.660.54
1.20.230.1300.020.020.020.020.020.010000000001711.980.110.18.159.447.19
6.533.962.742.73.763.124.674.514.154.845.877.357.736.357.510.0911.7211.2211.0327.2523.1519.9316.9527.1430.9424.51
0.21.431.130.10.080.060.040.030.010000000012.9812.98000.110.040.080.250.1
000.210.420.730.570.540.860.720.232.622.592.852.0920.90.330.14000003.694.764.77
1.241.320.650.822.983.383.653.313.573.23.363.312.923.623.644.123.153.383.634.224.864.584.772.280.920.94
1.442.741.991.343.784.014.234.24.293.435.985.895.765.715.645.033.4916.516.614.224.864.694.816.045.935.81
7.976.74.724.047.547.138.98.718.448.2711.8513.2413.4912.0613.1415.1115.227.7327.6431.4728.0124.6121.7733.1836.8730.32
14.4814.5120.0722.230.2735.8241.3150.350.4648.8661.3868.177169.0671.6376.1579.6986.976.7873.8573.1371.3571.15101.57120.09125.55
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Jin Yang Pharmaceutical Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Jin Yang Pharmaceutical Co's financial health and stability.

Assets

Jin Yang Pharmaceutical Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Jin Yang Pharmaceutical Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Jin Yang Pharmaceutical Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Jin Yang Pharmaceutical Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (B)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (B)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (B)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (B)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
0.341.082.523.454.574.644.723.721.63-0.241.126.543.491.062.534.194.010000.931.653.689.5412.31
0.130.170.170.320.370.660.950.980.971.021.071.181.181.121.010.930.891.031.612.052.112.112.112.152.29
00211214308-159-33211-59-608-361230000000000000
0.41-1.06-1.99-1.56-3.37-5.26-6.78-3.69-4.07-0.29-4.4-1.45-3.681.170.14-6.33-12.23-3.78-1.63-3.04-3.071.092.11-10.62-7.08
0.540.90.91.560.72.432.662.214.363.993.721.640.461.072.594.334.250001.090.87-1.650.9-0.07
0000000000004420549373374284182991598714
0000000000001.770.972.30.92.851.64-0.61-0.010.010.530.470.431.13
1.421.081.813.982.582.31.513.432.833.871.488.031.444.426.273.13-3.08-2.76-0.01-0.991.065.736.241.977.45
-96-86-191-470-6,543-4,952-917-1,205-1,451-916-1,393-2,015-712-925-884-2,633-3,062-14,516-4,081-1,177-327-751-1,371-2,723-4,641
1.21-1.2-1.9-2.56-4.55-3.04-1.77-5.263.31-5.24-1.42-2.95-0.53-1.5-7.682.03-2.46-12.71-2.63-3.57.420.461.37-4.28-12.83
1.3-1.12-1.71-2.091.991.91-0.85-4.064.76-4.32-0.03-0.940.18-0.58-6.84.660.611.81.45-2.327.741.212.74-1.55-8.19
0000000000000000000000000
-1.76-0.78-2.27-1.250.33-0.340.87-0.480.45-0.830.28-0.280-0.1-0.20214.28-1.524.97-7.38-3.44-3.149.87-0.19
00.32.94001.9708.44-0.39-1.63000-0.0600-0.98-0.03000000-2.57
-2.53-1.770.17-2.011.981.21-0.036.35-1.16-3.67-0.87-1.49-1.17-1.31-1.34-0.81.4313.13-1.234.45-8.5-4.56-4.158.85-5.58
-0.7-1.2-0.24-0.132.290.220.1-0.6-0.01-0.02-0.01-0.07-0.03-000.351.5501.410.6000.10.1-1.7
-78-80-264-640-640-640-1,000-1,000-1,200-1,189-1,144-1,144-1,144-1,144-1,142-1,142-1,143-1,118-1,117-1,117-1,117-1,117-1,117-1,117-1,117
0.09-1.890.08-0.5900.47-0.294.524.98-5.04-0.823.59-0.261.61-2.794.34-4.07-2.34-3.87-0.04-0.021.633.466.54-10.97
1,326.1997.51,614.83,512.3-3,965.8-2,653.6587.82,229.21,380.82,953.382.36,018.7727.43,496.95,384.4495.2-6,143.2-17,272.5-4,094.5-2,164.4731.24,975.64,873.1-752.942,806.38
0000000000000000000000000

Jin Yang Pharmaceutical Co stock margins

The Jin Yang Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jin Yang Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jin Yang Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jin Yang Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Jin Yang Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jin Yang Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jin Yang Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jin Yang Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jin Yang Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jin Yang Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jin Yang Pharmaceutical Co Margin History

Jin Yang Pharmaceutical Co Gross marginJin Yang Pharmaceutical Co Profit marginJin Yang Pharmaceutical Co EBIT marginJin Yang Pharmaceutical Co Profit margin
202361.05 %9.65 %13.45 %
202259.86 %14.61 %16.14 %
202154.08 %11.08 %15.18 %
202052.38 %7.26 %7.53 %
201950.82 %-0.46 %3.48 %
201855.03 %3.13 %1.99 %
201752.7 %-12.18 %-13.28 %
201647.83 %-27.62 %-25.18 %
201555.59 %-2.65 %-2.5 %
201461.91 %13.54 %8.87 %
201359.82 %12.14 %10.42 %
201258.93 %10.78 %6.8 %
201156.77 %1.01 %2.92 %
201059.45 %8.2 %8.53 %
200964.95 %15.88 %12.98 %
200866.01 %8.58 %2.66 %
200763.36 %-3.95 %-0.73 %
200666.26 %8.6 %4.8 %
200565.93 %19.33 %11.64 %
200466.57 %23.02 %15.57 %

Jin Yang Pharmaceutical Co Stock Sales Revenue, EBIT, Earnings per Share

The Jin Yang Pharmaceutical Co earnings per share therefore indicates how much revenue Jin Yang Pharmaceutical Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Jin Yang Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Jin Yang Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Jin Yang Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Jin Yang Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Jin Yang Pharmaceutical Co Revenue, EBIT and net profit per share

DateJin Yang Pharmaceutical Co Sales per ShareJin Yang Pharmaceutical Co EBIT per shareJin Yang Pharmaceutical Co Earnings per Share
20237,542.24 undefined728.1 undefined1,014.53 undefined
20225,673.25 undefined828.58 undefined915.61 undefined
20215,505.39 undefined610.09 undefined835.6 undefined
20204,437.27 undefined322.27 undefined334.27 undefined
20194,304.64 undefined-19.64 undefined149.73 undefined
20184,260.27 undefined133.18 undefined84.82 undefined
20173,950 undefined-481 undefined-524.36 undefined
20163,284.73 undefined-907.09 undefined-827.18 undefined
20153,649.91 undefined-96.64 undefined-91.27 undefined
20144,112.45 undefined556.73 undefined364.82 undefined
20133,657.73 undefined444 undefined381.18 undefined
20123,376.82 undefined364.18 undefined229.73 undefined
20113,296.55 undefined33.45 undefined96.18 undefined
20103,714.27 undefined304.55 undefined316.91 undefined
20094,581.09 undefined727.64 undefined594.55 undefined
20083,842.09 undefined329.55 undefined102.09 undefined
20072,754.67 undefined-108.83 undefined-20.17 undefined
20062,838.17 undefined244 undefined136.25 undefined
20053,195.4 undefined617.6 undefined372 undefined
20042,752.55 undefined633.64 undefined428.64 undefined

Jin Yang Pharmaceutical Co business model

Jin Yang Pharmaceutical Co is one of the most popular companies on Eulerpool.com.

Jin Yang Pharmaceutical Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Jin Yang Pharmaceutical Co historical P/E ratio, EBIT, and P/S ratio.

Jin Yang Pharmaceutical Co shares outstanding

The number of shares was Jin Yang Pharmaceutical Co in 2023 — This indicates how many shares 12.478 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Jin Yang Pharmaceutical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Jin Yang Pharmaceutical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Jin Yang Pharmaceutical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Jin Yang Pharmaceutical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Jin Yang Pharmaceutical Co Stock splits

In Jin Yang Pharmaceutical Co's history, there have been no stock splits.

Jin Yang Pharmaceutical Co dividend history and estimates

In 2023, Jin Yang Pharmaceutical Co paid a dividend amounting to 150 KRW. Dividend means that Jin Yang Pharmaceutical Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Jin Yang Pharmaceutical Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Jin Yang Pharmaceutical Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Jin Yang Pharmaceutical Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Jin Yang Pharmaceutical Co Dividend History

DateJin Yang Pharmaceutical Co Dividend
2023150 undefined
2022150 undefined
2021100 undefined
2020100 undefined
2019100 undefined
2018100 undefined
2017100 undefined
2016100 undefined
2015100 undefined
2014100 undefined
2013100 undefined
2012100 undefined
2011100 undefined
2010100 undefined
2009100 undefined
2008100 undefined
2007100 undefined
2006100 undefined
2005100 undefined
2004100 undefined

Jin Yang Pharmaceutical Co dividend payout ratio

In 2023, Jin Yang Pharmaceutical Co had a payout ratio of 19.42%. The payout ratio indicates the percentage of the company's profits that Jin Yang Pharmaceutical Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Jin Yang Pharmaceutical Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Jin Yang Pharmaceutical Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Jin Yang Pharmaceutical Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Jin Yang Pharmaceutical Co Payout Ratio History

DateJin Yang Pharmaceutical Co Payout ratio
202319.42 %
202216.38 %
202111.97 %
202029.92 %
201966.79 %
2018117.91 %
2017-19.07 %
2016-12.09 %
2015-109.57 %
201427.41 %
201326.23 %
201243.53 %
2011103.97 %
201031.56 %
200916.82 %
200897.95 %
2007-496.03 %
200673.39 %
200526.88 %
200423.33 %
Unfortunately, there are currently no price targets and forecasts available for Jin Yang Pharmaceutical Co.

Jin Yang Pharmaceutical Co list of shareholders

%
Name
Stocks
Change
Date
25.90263 % Choi (Jae Jun)2,940,080012/31/2023
2.11444 % Han (Su Ja)240,000012/31/2023
1.10127 % Choi (Jung Ho)125,000012/31/2023
0.79586 % Lee (Hye Rim)90,334012/31/2023
0.64755 % Choi (Min Seo)73,500012/31/2023
0.64755 % Choi (Yeon Seo)73,500012/31/2023
0.51980 % Choi (Yun Hwan)59,000012/31/2023
0.00073 % Multi Asset Global Investments Co., Ltd.83839/30/2023
0.00007 % Dimensional Fund Advisors, L.P.802/29/2024
1

Most common questions regarding Jin Yang Pharmaceutical Co

What is the P/E ratio of Jin Yang Pharmaceutical Co 2024?

The P/E ratio cannot be calculated for Jin Yang Pharmaceutical Co at the moment.

What is the P/S ratio of Jin Yang Pharmaceutical Co 2024?

The P/S cannot be calculated for Jin Yang Pharmaceutical Co currently.

What is the AlleAktien quality score of Jin Yang Pharmaceutical Co?

The AlleAktien quality score for Jin Yang Pharmaceutical Co is 5/10.

What is the revenue of Jin Yang Pharmaceutical Co 2024?

The revenue cannot currently be calculated for Jin Yang Pharmaceutical Co.

How high is the profit of Jin Yang Pharmaceutical Co 2024?

The profit cannot currently be calculated for Jin Yang Pharmaceutical Co.

What is the business model of Jin Yang Pharmaceutical Co

No history available for Jin Yang Pharmaceutical Co.

What is the Jin Yang Pharmaceutical Co dividend?

Jin Yang Pharmaceutical Co pays a dividend of 150 KRW distributed over payouts per year.

How often does Jin Yang Pharmaceutical Co pay dividends?

The dividend cannot currently be calculated for Jin Yang Pharmaceutical Co or the company does not pay out a dividend.

What is the Jin Yang Pharmaceutical Co ISIN?

The ISIN of Jin Yang Pharmaceutical Co is KR7007370000.

What is the Jin Yang Pharmaceutical Co ticker?

The ticker of Jin Yang Pharmaceutical Co is 007370.KQ.

How much dividend does Jin Yang Pharmaceutical Co pay?

Over the past 12 months, Jin Yang Pharmaceutical Co paid a dividend of 150 KRW . This corresponds to a dividend yield of about 2.8 %. For the coming 12 months, Jin Yang Pharmaceutical Co is expected to pay a dividend of 150 KRW.

What is the dividend yield of Jin Yang Pharmaceutical Co?

The current dividend yield of Jin Yang Pharmaceutical Co is 2.8 %.

When does Jin Yang Pharmaceutical Co pay dividends?

Jin Yang Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Jin Yang Pharmaceutical Co?

Jin Yang Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of Jin Yang Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 150 KRW are expected. This corresponds to a dividend yield of 2.8 %.

In which sector is Jin Yang Pharmaceutical Co located?

Jin Yang Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jin Yang Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jin Yang Pharmaceutical Co from 3/1/2024 amounting to 150 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Jin Yang Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/1/2024.

What was the dividend of Jin Yang Pharmaceutical Co in the year 2023?

In the year 2023, Jin Yang Pharmaceutical Co distributed 150 KRW as dividends.

In which currency does Jin Yang Pharmaceutical Co pay out the dividend?

The dividends of Jin Yang Pharmaceutical Co are distributed in KRW.

All fundamentals about Jin Yang Pharmaceutical Co

Our stock analysis for Jin Yang Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jin Yang Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.